1. What is the projected Compound Annual Growth Rate (CAGR) of the Peripheral IV Catheters?
The projected CAGR is approximately 3.3%.
MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.
Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.
Peripheral IV Catheters by Type (Safety, Conventional), by Application (Hospitals, ASC, Clinics, Home Healthcare, Others), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast 2025-2033
The global peripheral IV catheter market, valued at $4,297.5 million in 2025, is projected to experience steady growth, driven by a rising geriatric population requiring frequent intravenous therapies, increasing prevalence of chronic diseases necessitating long-term IV access, and advancements in catheter technology leading to improved patient comfort and reduced infection rates. Technological innovations such as implantable ports and midline catheters are expanding market applications and driving growth. However, challenges such as catheter-related bloodstream infections (CRBSIs) and the associated healthcare costs continue to act as market restraints. Furthermore, stringent regulatory approvals and increasing healthcare costs in several regions could temper market expansion. The market's segmentation likely includes variations in catheter material (e.g., polyurethane, silicone), gauge size, and insertion method (e.g., peripheral, midline, PICC). Competition is intense, with established players like Becton, Dickinson and Company, B. Braun Melsungen, and Teleflex dominating the market alongside emerging companies focusing on innovative designs and improved safety features.
Growth in the forecast period (2025-2033) will likely be influenced by several factors. Increased adoption of minimally invasive procedures, growing awareness of infection prevention strategies, and expanded access to healthcare in developing nations are likely to boost market expansion. A continued focus on improving catheter design to mitigate CRBSIs and enhance patient experience will be crucial for sustained market growth. Regional variations in healthcare infrastructure and spending will influence market penetration, with developed regions such as North America and Europe expected to maintain significant market shares due to higher healthcare expenditure and technological adoption rates. However, developing regions are anticipated to witness faster growth rates owing to rising healthcare spending and increasing disease prevalence.
The global peripheral IV catheters market exhibited robust growth throughout the historical period (2019-2024), driven by a confluence of factors including the rising prevalence of chronic diseases requiring intravenous therapy, an aging global population, and advancements in catheter technology. The market size, exceeding several million units annually by 2024, is projected to continue this upward trajectory throughout the forecast period (2025-2033). Key market insights reveal a significant shift towards technologically advanced catheters, such as those incorporating antimicrobial properties to reduce infection rates and improve patient safety. The demand for minimally invasive and patient-friendly catheters is also on the rise, influencing product development and innovation within the industry. Furthermore, increasing healthcare expenditure in developing economies is creating new market opportunities, particularly in regions with expanding healthcare infrastructure. The estimated market size for 2025 underscores the significant scale of the industry, highlighting its importance in modern healthcare delivery. Competitive dynamics are shaped by ongoing innovation, strategic acquisitions, and collaborations among leading players, all vying for market share in this lucrative sector. The focus is shifting towards providing comprehensive solutions, integrating catheters with advanced infusion systems and related technologies, leading to a more integrated and streamlined approach to intravenous therapy. This trend benefits both healthcare providers and patients alike. The rising adoption of advanced catheter materials, such as polyurethane and silicone, which offer improved biocompatibility and reduced complications, further fuels market expansion. Finally, stringent regulatory guidelines regarding catheter safety and efficacy are driving manufacturers to adhere to high quality standards, enhancing the overall reliability and performance of the devices.
Several key factors are propelling the growth of the peripheral IV catheters market. The escalating prevalence of chronic diseases, including cancer, diabetes, and cardiovascular disorders, necessitates frequent intravenous therapy, thus fueling demand for catheters. The aging global population is another significant driver, as older adults often require more extensive medical care, including intravenous medication and fluid administration. Technological advancements, such as the development of smaller gauge catheters, antimicrobial coatings, and improved catheter materials, are contributing to enhanced patient comfort, reduced complications, and increased efficacy. The growing adoption of minimally invasive procedures and outpatient care settings also necessitates the utilization of peripheral IV catheters. Furthermore, the increasing awareness among healthcare professionals and patients regarding the importance of infection control and patient safety is driving the demand for safer and more effective catheters. Finally, supportive government initiatives and regulatory approvals for innovative catheter designs are stimulating market growth, and expanding healthcare infrastructure in developing economies presents substantial untapped potential for market expansion.
Despite the promising growth prospects, the peripheral IV catheters market faces certain challenges. The high incidence of catheter-related complications, such as phlebitis, thrombosis, and infection, poses a significant concern and requires continuous improvements in catheter design and insertion techniques. The cost of advanced catheters can be prohibitive in certain healthcare settings, potentially limiting access to these crucial medical devices. Stringent regulatory approvals and quality control requirements can pose obstacles for manufacturers, particularly for smaller companies entering the market. Furthermore, intense competition among established players necessitates continuous innovation and adaptation to remain competitive. Fluctuations in raw material prices can also impact production costs and profitability. Lastly, the increasing focus on cost-containment measures within healthcare systems could constrain market growth, putting pressure on manufacturers to offer cost-effective solutions without compromising on quality and safety.
The North American market currently holds a significant share of the global peripheral IV catheters market, owing to its advanced healthcare infrastructure, high prevalence of chronic diseases, and high healthcare expenditure. However, developing economies in Asia-Pacific and Latin America are exhibiting rapid growth, driven by increasing healthcare awareness and investments in healthcare infrastructure.
Segments:
The segment exhibiting the most significant growth is likely the advanced catheter segment, which incorporates antimicrobial coatings or other features that reduce infection risks. The demand for these catheters is propelled by efforts to improve patient outcomes and reduce healthcare costs associated with infections. The market will also see considerable growth in developing economies, as investments in healthcare infrastructure and improvements to healthcare access lead to greater demand for peripheral IV catheters.
The peripheral IV catheter industry's growth is primarily fueled by increasing prevalence of chronic diseases, technological advancements, rising geriatric population, and expanding healthcare infrastructure, particularly in emerging economies. These factors together are creating a substantial demand for safe and effective peripheral IV catheters.
This report provides a comprehensive analysis of the peripheral IV catheters market, covering market trends, driving forces, challenges, key regions/segments, growth catalysts, leading players, and significant developments. The data presented offers valuable insights for stakeholders in the healthcare industry, providing a clear understanding of the market's dynamics and future prospects across the forecast period (2025-2033). The report incorporates historical data (2019-2024), estimates (2025), and forecasts up to 2033, providing a holistic view of the market's evolution. The analysis includes granular detail on market segmentation, competitive landscape, and emerging trends, empowering informed decision-making for industry participants.
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of 3.3% from 2019-2033 |
| Segmentation |
|




Note*: In applicable scenarios
Primary Research
Secondary Research

Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
The projected CAGR is approximately 3.3%.
Key companies in the market include Tangent Medical Technologies, Smith Medical, B. Braun Melsungen, C. R. Bard, Becton, Dickinson and Company, Argon Medical Devices, Terumo Corporation, Vygon SA, Teleflex, Vigmed AB, .
The market segments include Type, Application.
The market size is estimated to be USD 4297.5 million as of 2022.
N/A
N/A
N/A
N/A
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3480.00, USD 5220.00, and USD 6960.00 respectively.
The market size is provided in terms of value, measured in million and volume, measured in K.
Yes, the market keyword associated with the report is "Peripheral IV Catheters," which aids in identifying and referencing the specific market segment covered.
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
To stay informed about further developments, trends, and reports in the Peripheral IV Catheters, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.